Skip to main content
Advanced Technical IVT

atypical teratoid/rhabdoid tumour

Pronunciation: ay-TIP-ih-kal ter-ah-TOY-d RAB-doyd TOO-mer

A highly malignant embryonal CNS tumour of infancy and early childhood characterised by loss of SMARCB1 (INI1) or, rarely, SMARCA4 protein expression.

Full Definition

Atypical teratoid/rhabdoid tumour (AT/RT) is among the most aggressive paediatric brain tumours, typically occurring in children under three years of age and carrying a median survival of less than two years without intensive therapy. The tumour is defined by biallelic inactivation of SMARCB1 (encoding INI1) or, in a minority of cases, SMARCA4, with loss of nuclear expression confirmed by immunohistochemistry. Three molecular subgroups (AT/RT-TYR, AT/RT-SHH, AT/RT-MYC) have distinct epigenetic profiles and clinical behaviours. Editors should use the solidus (/) rather than a hyphen in 'AT/RT' and should note that the full form uses a forward slash between 'teratoid' and 'rhabdoid', which is non-standard punctuation that must be preserved.

Usage

Usage note: The solidus (/) between 'teratoid' and 'rhabdoid' is part of the official name and must be retained in all editorial contexts.

In Context

  • "Loss of INI1 nuclear immunoreactivity confirmed the diagnosis of atypical teratoid/rhabdoid tumour in the nine-month-old infant." — Neuropathology report
  • "The solidus in AT/RT is intentional and must not be replaced with a hyphen during copy-editing." — Editorial style note

Also known as

AT/RT atypical teratoid rhabdoid tumour

Don't confuse with

rhabdoid tumour of the kidney ETMR medulloblastoma

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON